@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_head { this: np:hasAssertion dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_assertion; np:hasProvenance dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_provenance; np:hasPublicationInfo dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_publicationInfo; a np:Nanopublication . dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_assertion a np:Assertion . dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_provenance a np:Provenance . dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_publicationInfo a np:PublicationInfo . } dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_assertion { miriam-gene:4893 a ncit:C16612 . lld:C0178874 a ncit:C7057 . dgn-gda:DGNc660009b434500eb806797a0db263511 sio:SIO_000628 miriam-gene:4893, lld:C0178874; a sio:SIO_001121 . } dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_provenance { dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_assertion dcterms:description "[Each example of an activated ras gene showed a mutation at the 61st codon of the protein, with the exception of one melanoma which showed a mutation at codon 13 of the N-ras gene; (2) all the melanomas displaying an activated ras gene had a similar cell surface phenotype and appear to come from a similar phase of differentiation; (3) 5-6% of noncultured primary and metastatic melanomas have mutated ras genes; (4) no ras gene mutations were found in any precursor lesion, specifically normal nevi and dysplastic nevi; (5) immunoperoxidase analysis of paraffin-embedded specimens indicated no quantitative or qualitative alterations in p21 expression that correlate with tumor progression; (6) there were no observable differences in p21 expression between melanoma cells growing exponentially or in plateau phase, or between melanoma cells with or without ras mutations; nor were any cell kinetic differences found between cells with and without mutated ras genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:2682463; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP598764.RAJR9nUZe3CJc4jxE4GhSBYWF4Y4RuvCSei4XeOmanvOk130_publicationInfo { this: dcterms:created "2015-08-25T14:43:38+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }